CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 6.8

ph-index = 6

Forward Citations = 101(Granted Patents)

Company Filing History:

Syngenta Participations Ag

Unitract Syringe Pty Ltd

patents

7. 1 out of 76

Synthetic Genomics, Inc.

patents

Years Active: 2011-2025

Loading Chart...

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12433994 - Drug delivery device, method of manufacture, and method of use (2025-10-07),

2. 12403251 - Device and method for making aseptic connections (2025-09-02),

3. 12201809 - Drug delivery device, method of manufacture, and method of use (2025-01-21),

4. 11484644 - Sterile fluid pathway connection to drug containers for drug delivery pumps (2022-11-01),

5. 11266777 - Drug delivery device, method of manufacture, and method of use (2022-03-08),

6. 11135356 - Controlled delivery drive mechanisms for drug delivery pumps (2021-10-05),

7. 11129936 - Drug delivery device, method of manufacture, and method of use (2021-09-28),

8. 11084205 - Operation of printing nozzles in additive manufacture and apparatus for cleaning printing nozzles (2021-08-10),

9. 11046005 - Waste disposal for 3D printing (2021-06-29),

10. 10611136 - Method and system for rotational 3D printing (2020-04-07),

11. 10569014 - Device and method for making aseptic connections (2020-02-25),

12. 10369274 - Sterile fluid pathway connection to drug containers for drug delivery pumps (2019-08-06),

13. 10092693 - Controlled delivery drive mechanisms for drug delivery pumps (2018-10-09),

14. 9707337 - Sterile fluid pathway connection to drug containers for drug delivery pumps (2017-07-18),

15. 9446407 - Lid mechanism (2016-09-20),

Title: Scott Beaver: Innovating Drug Delivery Solutions in San Marcos, CA

Introduction:

Scott Beaver, a prolific inventor based in San Marcos, CA, has made significant contributions to the field of drug delivery with his inventive patents and novel solutions.

Latest Patents:

With a total of 16 patents to his name, Scott Beaver's latest inventions include a revolutionary "Sterile fluid pathway connection to drug containers for drug delivery pumps" and a cutting-edge "Drug delivery device, method of manufacture, and method of use." These patents showcase his ingenuity and commitment to advancing healthcare technologies.

Career Highlights:

Having worked at notable companies such as Unl Holdings LLC and Amgen Inc., Scott Beaver has honed his skills and expertise in the pharmaceutical and biotechnology industries. His innovative spirit has led to the development of groundbreaking solutions that have the potential to improve patient outcomes and quality of life.

Collaborations:

Throughout his career, Scott Beaver has collaborated with talented individuals in the field, including coworkers like Ian B. Hanson and Kevin Lee Bokelman. These partnerships have fueled innovation and driven the success of his projects, highlighting the importance of teamwork in the invention process.

Conclusion:

In conclusion, Scott Beaver stands as a visionary inventor in the realm of drug delivery, with a remarkable track record of patents and a dedication to pushing the boundaries of what is possible in healthcare innovation. His contributions are shaping the future of the industry and have the potential to make a lasting impact on patients worldwide.

This text is generated by artificial intelligence and may not be accurate.